TELIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Telix Pharmaceuticals Limited on Behalf of Telix Stockholders and Encourages Investors to Contact the Firm

Benzinga
2025.08.23 14:33

Bragar Eagel & Squire, P.C. 正在代表其股東調查 Telix Pharmaceuticals Limited，原因是可能違反聯邦證券法。此次調查是在 Telix 披露了來自 SEC 的傳票後進行的，該傳票涉及其前列腺癌治療候選藥物，這導致其 ADR 價格下跌了 10.44%。遭受損失的投資者被鼓勵聯繫該公司以尋求法律選項

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.